Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging

BACKGROUND: Most metastatic gastrointestinal stromal tumors (GISTs) develop resistance to the first-line imatinib treatment. Recently, increased vessel density and angiogenic markers were reported in GISTs with a poor prognosis, suggesting that angiogenesis is implicated in GIST tumor progression an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Gastric Cancer
Prif Awduron: Consolino, Lorena, Longo, Dario Livio, Sciortino, Marianna, Dastrù, Walter, Cabodi, Sara, Giovenzana, Giovanni Battista, Aime, Silvio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Japan 2016
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486478/
https://ncbi.nlm.nih.gov/pubmed/27995483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-016-0672-7
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg